期刊文献+

比阿培南对鲍曼不动杆菌的抗菌活性评价 被引量:7

The evaluation of antibacterial activity of Biapenem against Acinetobacter baumannii in vitro
下载PDF
导出
摘要 目的:评价比阿培南对鲍曼不动杆菌的体外抗菌活性。方法:应用琼脂稀释法测定比阿培南、美罗培南、亚胺培南、头孢他啶对临床分离出的30株鲍曼不动杆菌的最低抑菌浓度(MIC),并计算MIC50和MIC90。结果:比阿培南、美罗培南、亚胺培南、头孢他啶的MIC50分别为2、4、2、128μg/ml,MIC90分别为16、32、32μg/ml、512μg/ml,耐药率分别为20.0%、30.0%、33.3%、70.0%。结论:比阿培南与其他3种药物比较对鲍曼不动杆菌有更强的体外抗菌活性。 Objective:To evaluate the antibacterial activity of Biapenen on Acinetobacter baumannii in vitro.Methods:The MICs of Biapenem,Meropenem,Imipenem and Ceftazidime were tested by agar dilution method on 30 selected Acine tobacter baumannii strains.And then compared them.Results:The MIC50 of Biapenem,Meropenem,Imipenem were 2,4,2,128 μg/ml and the MIC90 of them were 16,32,32 μg/ml,512 μg/ml.The resistance rates were as follows:20.0%,30.0%,33.3%,70.0%.Conclusion:The antibacterial activity of Biapenem on Acinetobacter baumannii in vitro is stronger than the other 3 kinds of drugs.
出处 《中国医药导报》 CAS 2010年第33期44-45,共2页 China Medical Herald
关键词 比阿培南 鲍曼不动杆菌 抗菌活性 Biapenem Acinetobacter baumannii Antibacterial activity
  • 相关文献

参考文献7

  • 1Haluk V,Fatma B,Murat K,et al.High prevalence of OXA-51-type class D β-lactamases among ceftazidime-resistant clinical isolates of Aeinetobacter spp.:co-existence with OXA-58 in multiple centres[J].J Antimicrob Chemother,2006,58(3):537.
  • 2王金良.密切注视鲍曼不动杆菌的耐药发展趋势[J].中华检验医学杂志,2005,28(4):355-356. 被引量:194
  • 3Chen HY,Livermore DM.In-vitro activity of biapenem,compared with imipenem and meropenem,against Pseudomonas acruginosa strains and mutants with known resistance mechanisms[J].J Antimicrob Chemother,1994,33(5):949-958.
  • 4Hirakata Y,Matsuda J,Mochida c,et al.Annual changes is susceptibility of clinical isolates to biapenem in Japanese[J].Jpn J Chemother,2002,50(6):329-351.
  • 5崔银珠.新型抗菌药物比阿培南(biapenem)[J].世界临床药物,2003,24(9):572-573. 被引量:10
  • 6Hiraishi T,Miyata A,Hara T,et al.Bactericidal activity for biapenem against various bacteria[J].Jpn J Antibiot,2001,54(12):581.
  • 7Sirot D.Extend-spectrum plasmid-mediated β-lactamases[J].Jantimicrob Chemother,1995,36(Suppl A):19-34.

二级参考文献25

  • 1王辉,刘颖梅,陈民钧,孙宏莉,谢秀丽,徐英春.鲍曼不动杆菌对碳青霉烯类耐药机制的研究[J].中国医学科学院学报,2003,25(5):567-572. 被引量:44
  • 2周月清,陆开来,糜祖煌.鲍曼不动杆菌TEM基因及氨基糖苷类修饰酶基因初步研究[J].中华检验医学杂志,2005,28(2):200-202. 被引量:64
  • 3黄金竹,母连军.碳青霉烯类抗生素的研究概况[J].国外医药(抗生素分册),2007,28(4):145-154. 被引量:45
  • 4Afcal-shah M, Lirermore DM. Worldwide emergency of carbapenem-resistant Acinetobacter spp.J Antimicrob Chemother, 1998,41:576-577.
  • 5Dalla-costa LM, Coelho JM, Souza HA, et al .Outbreak of carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme in Curitiba,Brazil J Clin Microbiol ,2003,41:3403-3406.
  • 6Lepez-Otsoa F, Gallego L, Towner KJ,et al.Endemic carbapenem resistance associated with OXA-40 carbapenemase among Acinetobacter baumannii isolated from a hospital in northern Spain.J Clin Microbiol, 2002,40:4741-4743.
  • 7Zarrilli R, Crispino M, Bagattini M,et al.Molecular epidemiology of sequential outbreak of Acinetobacter baumannii in an ICU shows the emergence of carbapenem resistance.J Clin Microbiol ,2004,42:946-953.
  • 8Koeleman JG, Stoof J, van der Bijl, et al. Identification of epidemic strains of Acinetobacter baumannii by integrase gene PCR. J Clin Microbiol ,2001,39:8-13.
  • 9史伟峰 姜建平 徐宁.鲍曼不动杆菌多药外排作用与耐药性的关系[A]..全国检验医学感染控制和病原监测学术研讨会论文集[C].,2004.139-141.
  • 10Limansky AS,Mussi MA, Viale AM . Loss of 29 kD outer membrane protein in Acenetobacter baumanii is associated with Imipenem resistance. J Clin Microbiol ,2002,40:4776-4778.

共引文献202

同被引文献84

引证文献7

二级引证文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部